AIM
IMVT icon

Aigen Investment Management’s Immunovant IMVT Stock Holding History

Aigen Investment Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,134
Closed -$308K – 787
2025
Q3 		$308K Buy
+19,134
New +$310K 0.05% 528
2025
Q1 		– Sell
-10,898
Closed -$270K – 876
2024
Q4 		$270K Buy
+10,898
New +$309K 0.05% 513
2024
Q3 		– Sell
-13,323
Closed -$352K – 858
2024
Q2 		$352K Buy
+13,323
New +$379K 0.07% 429
2023
Q3 		– Sell
-23,710
Closed -$450K – 947
2023
Q2 		$450K Buy
+23,710
New +$442K 0.07% 379

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Aigen Investment Management's IMVT Position: Q4 2025 in Review

Aigen Investment Management sold out of Immunovant (IMVT) in Q4 2025, closing a stake of 19,134 shares — an estimated $308K sold.

Aigen Investment Management first reported a position in IMVT in Q2 2023 and held it in 4 quarters. The position peaked at $450K in Q2 2023. 197 funds tracked by Wall St. Rank hold IMVT as of Q4 2025.

  • Aigen Investment Management reported no remaining Immunovant position as of Q4 2025 after selling out during the quarter.
  • Aigen Investment Management sold 19,134 Immunovant shares in Q4 2025, an estimated $308K.
  • Aigen Investment Management first reported a position in Immunovant in Q2 2023 and held it in 4 quarters.
  • Aigen Investment Management's Immunovant position peaked at $450K in Q2 2023.
  • 197 funds tracked by Wall St. Rank held Immunovant as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.